4//SEC Filing
Brown Jade 4
Accession 0000891293-06-000019
CIK 0000891293other
Filed
Jun 25, 8:00 PM ET
Accepted
Jun 26, 8:21 PM ET
Size
16.5 KB
Accession
0000891293-06-000019
Insider Transaction Report
Form 4
Brown Jade
EVP, Chief Business Officer
Transactions
- Sale
Common Stock
2006-06-23$1.38/sh−400$552→ 77,096 total - Sale
Common Stock
2006-06-23$1.42/sh−3,400$4,828→ 68,696 total - Sale
Common Stock
2006-06-23$1.44/sh−100$144→ 67,996 total - Sale
Common Stock
2006-06-23$1.41/sh−2,800$3,948→ 72,096 total - Award
Incentive Stock Option (right to buy)
2006-06-22+30,000→ 30,000 totalExercise: $1.42Exp: 2016-06-22→ Common Stock (30,000 underlying) - Sale
Common Stock
2006-06-23$1.40/sh−1,800$2,520→ 74,896 total - Sale
Common Stock
2006-06-23$1.43/sh−600$858→ 68,096 total
Footnotes (2)
- [F1]The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan. Proceeds from the sale were used to cover taxes related to the vesting of restricted stock on June 16, 2006.
- [F2]The reporting person was granted incentive stock options which will vest upon satisfaction of a confidential performance goal.
Documents
Issuer
CELL THERAPEUTICS INC
CIK 0000891293
Entity typeother
Related Parties
1- filerCIK 0001336984
Filing Metadata
- Form type
- 4
- Filed
- Jun 25, 8:00 PM ET
- Accepted
- Jun 26, 8:21 PM ET
- Size
- 16.5 KB